By using this site, you are consenting to our use of cookies. To find out more visit our privacy policy.
Modified Medical Research Council Questionnaire (of Dyspnea Scale) for COPD
Summary
What it measures:
Used to measure the degree of breathlessness related to activities.
Target Population:
People with chronic obstructive pulmonary disease (COPD)
Members Only Content
Join APTA to get unlimited access to content including evidence-based research, guidance on payment changes, and other resources to help you thrive. Learn more about membership benefits.
Already a member? Log in
Date: January 21, 2013
Contact: practice@apta.org
Content Type: Test & Measure
You Might Also Like...
CPG
Respiratory Management of Patients With Neuromuscular WeaknessMar 13, 2023
This joint guideline by the American College of Chest Physicians and Canadian Thoracic Society covers the prevention of acute exacerbations experienced
CPG
COVID-19 Rapid Guideline: Managing Symptoms (Including at the End of Life) in the Community [NG191]Mar 23, 2021
Recommendations for managing COVID‑19 symptoms for patients in the community -- babies, children, young people, and adults in all care settings, including
CPG
Idiopathic Pulmonary Fibrosis in Adults: Diagnosis and Management [NICE CG163] [Updated]May 23, 2017
Guideline covers diagnosing and managing idiopathic pulmonary fibrosis in people aged 18 and over.